Fundsmith LLP Terry Smith
London, X0 20 processed 13Fs on this site, 2021 Q3 to 2026 Q2
- $13.6B
- 41 holdings
- 2026 Q2
- +6.4% QoQ
- Top 5 29.8%
AUM over time
Book
| WAT, Waters | Reduce −10.0% | 3,557,978 | $379.83 | $1.4B | −397,520 | +$166M | |
| SYK, Stryker | Reduce −19.7% | 3,687,511 | $351.47 | $1.3B | −903,782 | −$401M | |
| IDXX, Idexx Laboratories | Reduce −28.1% | 1,876,035 | $676.53 | $1.3B | −734,422 | −$399M | |
| V, Visa | Reduce −8.3% | 3,534,684 | $350.71 | $1.2B | −319,652 | −$76M | |
| MAR, Marriott | Reduce −5.9% | 3,979,927 | $310.24 | $1.2B | −248,371 | +$134M | |
| GOOGL, Alphabet | Reduce −44.4% | 3,498,519 | $313.00 | $1.1B | −2,790,833 | −$434M | |
| ADP, Automatic Data Processing | Reduce −3.1% | 4,177,969 | $257.23 | $1.1B | −133,634 | −$191M | |
| MSFT, Microsoft | Reduce −19.5% | 2,079,971 | $483.62 | $1B | −503,398 | −$332M | |
| PM, Philip Morris International | Reduce −14.8% | 6,124,597 | $160.40 | $982M | −1,063,547 | −$184M | |
| META, Meta Platforms | Reduce −12.5% | 1,363,539 | $660.09 | $900M | −195,125 | −$245M | |
| MTD, Mettler-Toledo | Reduce −1.7% | 580,507 | $1,394 | $809M | −10,147 | +$84M | |
| PG, Procter & Gamble | Reduce −7.2% | 4,248,048 | $143.31 | $609M | −328,992 | −$94M | |
| CHD, Church & Dwight | Reduce −1.0% | 6,728,404 | $83.85 | $564M | −66,240 | −$31M | |
| FTNT, Fortinet | Reduce −22.6% | 6,516,011 | $79.41 | $517M | −1,904,081 | −$191M | |
| ZTS, Zoetis | Add +7.9% | 3,900,803 | $125.82 | $491M | +285,672 | −$38M | |
| TXN, Texas Instruments | Reduce −3.6% | 2,623,552 | $173.49 | $455M | −98,329 | −$45M | |
| INTU, Intuit | Add +3.5% | 625,619 | $662.42 | $414M | +21,163 | +$1.6M | |
| NKE, Nike | Reduce −5.9% | 5,770,181 | $63.71 | $368M | −359,302 | −$60M | |
| OTIS, Otis Worldwide | Reduce −46.5% | 3,112,380 | $87.35 | $272M | −2,706,771 | −$260M | |
| MSCI | Hold | 166,619 | $573.73 | $96M | — | — | |
| ROL, Rollins | Hold | 1,478,629 | $60.02 | $89M | — | — | |
| QLYS, Qualys | Reduce −25.6% | 647,806 | $132.90 | $86M | −223,053 | −$29M | |
| PAYC, Paycom Software | Hold | 523,433 | $159.36 | $83M | — | — | |
| Holding | Add +46.4% | 2,074,167 | $40.18 | $83M | +657,211 | −$4.9M | |
| Catalyst Pharmaceuticals | Hold | 3,363,807 | $23.34 | $79M | — | — | |
| NSSC, Napco Sec Technologies | Hold | 1,779,857 | $41.70 | $74M | — | — | |
| DOCS, Doximity | Add +21.7% | 1,650,002 | $44.28 | $73M | +294,058 | −$26M | |
| NTNX, Nutanix | New | 1,377,158 | $51.69 | $71M | +1,377,158 | +$71M | |
| VRT, Vertiv | Reduce −30.5% | 410,944 | $162.01 | $67M | −180,506 | −$23M | |
| VRSN, VeriSign | Hold | 270,634 | $242.95 | $66M | — | — | |
| CLX, Clorox | Hold | 613,497 | $100.83 | $62M | — | — | |
| MANH, Manhattan Associates | Hold | 288,332 | $173.31 | $50M | — | — | |
| GGG, Graco | Reduce −35.7% | 579,016 | $81.97 | $47M | −321,529 | −$29M | |
| MEDP, Medpace | Reduce −35.3% | 82,567 | $561.65 | $46M | −44,970 | −$19M | |
| ADMA, Adma Biologics | New | 2,102,054 | $18.24 | $38M | +2,102,054 | +$38M | |
| SABR, Sabre | Hold | 21,499,095 | $1.36 | $29M | — | — | |
| HD, Home Depot | Reduce −5.5% | 80,206 | $344.10 | $28M | −4,654 | −$6.8M |
Filings history
20 periods, with AUM normalized
| Period | Holds | AUM | QoQ | Form | Filed | Filing ID |
|---|---|---|---|---|---|---|
| 2026 Q2 | 41 | $13.6B | +6.4% | 13F-HR | 8/14/2026 | 000156920526000012 |
| 2026 Q1 | 34 | $12.8B | −25.1% | 13F-HR | 5/15/2026 | 000156920526000005 |
| 2025 Q4 | 37 | $17.1B | −13.5% | 13F-HR | 2/17/2026 | 000156920526000002 |
| 2025 Q3 | 35 | $19.8B | −14.0% | 13F-HR | 11/14/2025 | 000156920525000004 |
| 2025 Q2 | 39 | $23B | +4.7% | 13F-HR | 8/14/2025 | 000180154725000008 |
| 2025 Q1 | 38 | $22B | −6.3% | 13F-HR | 5/15/2025 | 000152002325000003 |
| 2024 Q4 | 38 | $23.5B | −7.2% | 13F-HR | 2/14/2025 | 000152002325000002 |
| 2024 Q3 | 40 | $25.3B | +3.0% | 13F-HR | 11/14/2024 | 000152002324000040 |
| 2024 Q2 | 40 | $24.5B | −4.0% | 13F-HR | 8/14/2024 | 000152002324000030 |
| 2024 Q1 | 40 | $25.6B | +7.0% | 13F-HR | 5/15/2024 | 000152002324000020 |
| 2023 Q4 | 40 | $23.9B | +8.5% | 13F-HR | 2/14/2024 | 000152002324000014 |
| 2023 Q3 | 39 | $22B | −7.7% | 13F-HR | 11/14/2023 | 000152002323000012 |
| 2023 Q2 | 39 | $23.8B | +2.8% | 13F-HR | 8/14/2023 | 000152002323000011 |
| 2023 Q1 | 40 | $23.2B | +5.8% | 13F-HR | 5/15/2023 | 000152002323000010 |
| 2022 Q4 | 38 | $21.9B | +3.9% | 13F-HR | 2/14/2023 | 000152002323000001 |
| 2022 Q3 | 46 | $21.1B | −7.0% | 13F-HR | 11/14/2022 | 000152002322000010 |
| 2022 Q2 | 43 | $22.7B | −22.2% | 13F-HR | 8/15/2022 | 000152002322000009 |
| 2022 Q1 | 44 | $29.1B | −28.9% | 13F-HR | 5/16/2022 | 000152002322000006 |
| 2021 Q4 | 44 | $41B | +13.3% | 13F-HR | 2/14/2022 | 000186853722000005 |
| 2021 Q3 | 43 | $36.2B | — | 13F-HR | 11/12/2021 | 000152002321000007 |
About
Fundsmith LLP
20 processed 13Fs on this site, 2021 Q3 to 2026 Q2